Blood pressure control and hormone replacement therapy in postmenopausal women at risk for coronary heart disease

American Heart Journal

Volumn 143, Issue 4, 2002, Pages 711-717

  McCubbin, James A ^a   Helfer, Suzanne G ^a   Switzer III, Fred S ^a   Price, Thomas M ^a  

^a CLEMSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; HORMONE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CORONARY RISK; ESTROGEN THERAPY; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0036238140     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.121262     Document Type: Article

References (46)

1. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture
2. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
3. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting
4. Estrogen replacement therapy and prognosis after first myocardial infarction
5. Estrogen replacement therapy after coronary angioplasty in women
6. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women
7. Hormone therapy to prevent disease and prolong life in postmenopausal women
8. Decreased mortality in users of estrogen replacement therapy
9. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study
10. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) research group
11. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from clinical trials
12. Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women
13. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
14. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial
15. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women
16. The protective effects of estrogen on the cardiovascular system
17. Inhibition of coronary atherosclerosis by propranalol in behaviorally predisposed monkeys fed an atherogenic diet
18. Premenopausal and postmenopausal women differ in their cardiovascular and neuroendocrine responses to behavioral stressors
19. Neuroendocrine and cardiovascular stress reactivity in middle-aged normotensive adults with parental history of cardiovascular disease
20. Hypertension risk factors and cardiovascular reactivity to mental stress in young men
21. Cardiovascular responses to behavioral stress and hypertension: A meta-analytic review
22. Altered pituitary hormone response to naloxone in hypertension development
23. Mortality and coronary heart disease among men studied for 23 years
24. Behaviorally induced heart rate reactivity and atherosclerosis in cynomolgus monkeys
25. Behaviorally elicited heart rate reactivity and atherosclerosis in female cynomolgus monkeys
26. Current status of coronary prevention. Lessons from the Framingham study
27. A prospective study of parental history of myocardial infarction and coronary heart disease in women
28. Parental history of essential hypertension, active coping, and cardiovascular reactivity
29. How accurately do adult sons and daughters report and perceive parental deaths from coronary disease?
30. Glycemic response to stress is altered in euglycemic Pima Indians
31. The effects of family history of hypertension and urbanization on blood pressures in normotensive, Zimbabwean young adults
32. Prenatal maternal blood pressure response to stress predicts birthweight and gestational age: A preliminary study
33. Primary prevention of coronary heart disease in women through diet and lifestyle
34. Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk study
35. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries
36. Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys
37. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys
38. Acute psychophysiologic reactivity and risk of cardiovascular disease: A review and methodologic critique
39. Exaggerated blood pressure responses during mental stress are associated with enhanced carotid atherosclerosis in middle-aged Finnish men: Findings from the Kuopio Ischemic Heart Disease study
40. Cardiovascular reactivity to the cold pressor test as a predictor of hypertension
41. Cardiovascular stress response and coronary artery disease: Evidence of an adverse postmenopausal effect in women
42. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen
43. Ovarian steroids and serotonin neural function
44. A longitudinal study of hormone replacement therapy and cardiovascular reactivity
45. Status, stress and atherosclerosis: The role of environment and individual behavior